Nkarta, Inc. Earnings Per Share, Basic and Diluted
Nkarta, Inc. (NKTX) reported Earnings Per Share, Basic and Diluted of -$0.79 per share for the 3-month period ending 2022-03-31, per its 10-Q filed 2022-05-12.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-05-12
- Nkarta, Inc. earnings per share, basic and diluted for the quarter ending 2022-03-31 was -$0.79.
- Nkarta, Inc. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.69.
- Nkarta, Inc. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.68.
- Nkarta, Inc. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.66.
- Nkarta, Inc. earnings per share, basic and diluted for fiscal 2021 was -$2.62.
- Nkarta, Inc. earnings per share, basic and diluted for fiscal 2020 was -$5.44.
- Nkarta, Inc. earnings per share, basic and diluted for fiscal 2019 was -$14.41.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2022-03-31 | -$0.79 10-Q · filed 2022-05-12 | -$1.48 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.16 derived: net income ÷ weighted average shares · filed 2023-11-09 | -$2.82 derived: net income ÷ weighted average shares · filed 2023-11-09 |
| 2021-12-31 | -$0.69 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$1.37 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$2.03 derived: net income ÷ weighted average shares · filed 2023-03-16 | -$2.62 10-K · filed 2022-03-17 |
| 2021-09-30 | -$0.68 10-Q · filed 2021-11-10 | -$1.34 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.93 10-Q · filed 2021-11-10 | -$2.47 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-06-30 | -$0.66 10-Q · filed 2021-08-12 | -$1.25 10-Q · filed 2021-08-12 | -$1.79 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$2.24 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2021-03-31 | -$0.59 10-Q · filed 2022-05-12 | -$1.14 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$1.59 derived: net income ÷ weighted average shares · filed 2022-11-09 | -$4.16 derived: net income ÷ weighted average shares · filed 2022-11-09 |
| 2020-12-31 | -$0.55 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$0.99 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$3.79 derived: net income ÷ weighted average shares · filed 2022-03-17 | -$5.44 10-K · filed 2022-03-17 |
| 2020-09-30 | -$0.44 10-Q · filed 2021-11-10 | -$3.96 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$6.39 10-Q · filed 2021-11-10 | -$9.36 derived: net income ÷ weighted average shares · filed 2021-11-10 |
| 2020-06-30 | -$30.06 10-Q · filed 2021-08-12 | -$36.13 10-Q · filed 2021-08-12 | -$43.08 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$45.43 derived: net income ÷ weighted average shares · filed 2021-11-10 |
| 2020-03-31 | -$5.41 10-Q · filed 2021-05-13 | -$12.02 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$13.89 derived: net income ÷ weighted average shares · filed 2021-11-10 | -$17.37 derived: net income ÷ weighted average shares · filed 2021-11-10 |
| 2019-12-31 | -$6.62 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$8.45 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$11.89 derived: net income ÷ weighted average shares · filed 2021-03-25 | -$14.41 10-K · filed 2021-03-25 |
| 2019-09-30 | -$1.75 10-Q · filed 2020-11-12 | -$5.08 derived: net income ÷ weighted average shares · filed 2020-11-12 | -$7.45 10-Q · filed 2020-11-12 | |
| 2019-06-30 | -$3.39 10-Q · filed 2020-08-20 | -$5.79 10-Q · filed 2020-08-20 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ORAMED PHARMACEUTICALS INC. (ORMP) | $0.199B | 1.13 | |
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B | |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| NATURES SUNSHINE PRODUCTS INC (NATR) | United States | $0.228B | 20.51 |